Seroprevalence of Chikungunya Virus, Jamaica, and New Tools for Surveillance Response

References 1. Anzinger JJ, Mears CD, Ades AE, Francis K, Phillips Y, Leys YE, et al.; ZIKAction Consortium1,2. Antenatal seroprevalence of Zika and chikungunya viruses, Kingston metropolitan area, Jamaica, 2017–2019. Emerg Infect Dis. 2022;28:473–5. https://doi.org/10.3201/eid2802.211849 2. Freitas ARR, Gérardin P, Kassar L, Donalisio MR. Excess deaths associated with the 2014 chikungunya epidemic in Jamaica. Pathogens and Global Health. 2019;113:27–31. https://doi.org/10.1080/20477724.2019.1574111 3. Evans-Gilbert T. Chikungunya and neonatal immunity: fatal vertically transmitted chikungunya infection. Am J Trop Med Hyg. 2017;96:913–5. https://doi.org/10.4269/ ajtmh.16-0491 4. Sharp TM, Ryff KR, Alvarado L, Shieh W-J, Zaki SR, Margolis HS et al. Surveillance for chikungunya and dengue during the first year of chikungunya virus circulation in Puerto Rico. J Infect Dis. 2016;214(suppl_5):S475–81. https://doi.org/10.1093/infdis/jiw245 5. Freitas ARR, Donalisio MR, Alarcón-Elbal PM. Excess mortality and causes associated with chikungunya, Puerto Rico, 2014–2015. Emerg Infect Dis. 2018;24:2352–5. https://doi.org/10.3201/eid2412.170639